https://www.mlo-online.com/diagnostics/assays/news/55373438/arteras-ai-prostate-and-breast-cancer-assays-now-ce-markedMLO Onlineen2026-04-24T19:02:07.000ZArtera’s AI Prostate and Breast Cancer Assays now CE markedhttps://www.mlo-online.com/disease/antibiotic-resistance/news/55373427/escmid-presented-research-finds-antibiotic-resistance-genes-in-newbornsMLO Onlineen2026-04-24T18:47:35.000ZESCMID-presented research finds antibiotic resistance genes in newbornshttps://www.mlo-online.com/information-technology/news/55373422/seegene-at-escmid-global-2026MLO Onlineen2026-04-24T18:39:34.000ZSeegene at ESCMID Global 2026https://www.mlo-online.com/disease/diabetes/news/55373413/study-finds-association-between-genetics-vitamin-d-and-diabetes-preventionMLO Onlineen2026-04-24T18:21:24.000ZStudy finds association between genetics, vitamin D, and diabetes preventionhttps://www.mlo-online.com/management/news/55373387/medica-and-compamed-announce-new-topics-and-formats-for-the-2026-showMLO Onlineen2026-04-24T17:27:39.000ZMEDICA and COMPAMED announce new topics and formats for the 2026 showhttps://www.mlo-online.com/management/news/55373377/medica-compamed-messe-dusseldorf-director-deep-dives-into-program-updatesMLO Onlineen2026-04-24T17:17:14.000ZMEDICA & COMPAMED, Messe Düsseldorf Director deep dives into program updateshttps://www.mlo-online.com/diagnostics/news/55373311/supporting-opioid-risk-assessment-fda-grants-solvd-health-pma-supplement-approvalMLO Onlineen2026-04-24T15:08:12.000ZSupporting opioid risk assessment: FDA grants SOLVD Health PMA supplement approval